Literature DB >> 2021990

Diphenhydramine prevents the haemodynamic changes of cimetidine in ICU patients.

K Omote1, A Namiki, H Iwasaki, Y Ujike.   

Abstract

Cimetidine, a histamine 2 (H2) antagonist, produces a decrease in arterial pressure due to vasodilatation, especially in critically ill patients. This may be because cimetidine acts as a histamine agonist. We, therefore, investigated the effects of the histamine 1(H1) receptor antagonist, diphenhydramine, on the haemodynamic changes observed after cimetidine in ICU patients. Each patient was studied on two separate days. In a random fashion, they received cimetidine 200 mg iv on one day, and on the other, a pretreatment of diphenhydramine 40 mg iv with cimetidine 200 mg iv. In the non-pretreatment group, mean arterial pressure (MAP) decreased from 107.4 +/- 8.4 mmHg to 86.7 +/- 11.4 mmHg (P less than 0.01) two minutes after cimetidine. Also, systemic vascular resistance (SVR) decreased during the eight-minute observation period (P less than 0.01). In contrast, in the pretreatment group, little haemodynamic change was seen. We conclude that an H1 antagonist may be useful in preventing hypotension caused by iv cimetidine, since the vasodilating activity of cimetidine is mediated, in part, through the H1 receptor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2021990     DOI: 10.1007/BF03008147

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  7 in total

1.  The hemodynamic effects of intravenous cimetidine versus ranitidine in intensive care unit patients: a double-blind, prospective, cross-over study.

Authors:  D B Coursin; C Farin-Rusk; S R Springman; S L Goelzer
Journal:  Anesthesiology       Date:  1988-12       Impact factor: 7.892

2.  The hemodynamic effects of intravenous cimetidine in intensive care unit patients: a double-blind, prospective study.

Authors:  T J Iberti; T A Paluch; L Helmer; V A Murgolo; E Benjamin
Journal:  Anesthesiology       Date:  1986-01       Impact factor: 7.892

3.  [Comparative studies on hemodynamic effects of intravenous cimetidine, ranitidine and famotidine in intensive care unit patients].

Authors:  K Omote; A Namiki; S Sumita; T Takahashi; Y Ujike; T Hagiwara
Journal:  Masui       Date:  1987-06

4.  Pharmacological characterisation of cardiovascular histamine receptors in man in vivo.

Authors:  M J Boyce
Journal:  Klin Wochenschr       Date:  1982-09-01

5.  Cardiovascular effects of cimetidine.

Authors:  H Kato; J Kurihara; Y Kasuya
Journal:  Arch Int Pharmacodyn Ther       Date:  1981-02

6.  Haemodynamic effects of the i.v. administration of cimetidine or ranitidine in the critically ill patient. A double-blind prospective study.

Authors:  C L Smith; D M Bardgett; J M Hunter
Journal:  Br J Anaesth       Date:  1987-11       Impact factor: 9.166

7.  Ranitidine produces minimal hemodynamic depression in stable intensive care unit patients: a double-blind, prospective study.

Authors:  S L Goelzer; C Farin-Rush; D B Coursin
Journal:  Crit Care Med       Date:  1988-01       Impact factor: 7.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.